斯坦丁相关的肌肉症状和维生素D补充剂
Kahtan Fadah1, Adriana Mares2, Richard A Lange1
1Division of Cardiology, Department of Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas.
Current opinion in cardiology
|April 4, 2025
概括
维生素D补充剂可能无法预防与他类药物相关的肌肉症状 (SAMS),尽管有观察性联系. 最近的大型试验显示,改善他类药物耐受性或降低停药率没有显著的益处.
科学领域:
- 心血管医学 心血管医学
- 内分泌学 在内分泌学.
- 营养科学 营养科学
背景情况:
- 类药物对于预防心血管疾病至关重要,但通常会引起肌肉症状 (SAMS),影响10-20%的用户.
- 类他类药物相关的肌肉症状 (SAMS) 降低了患者的坚持和治疗疗效.
- 维生素D缺乏是SAMS的潜在可改变的风险因素.
研究的目的:
- 审查维生素D在缓解他类药物相关肌肉症状 (SAMS) 中的作用.
- 阐明SAMS背后的复杂机制以及血清维生素D水平的影响.
主要方法:
- 观察性研究和最近的大规模临床试验的审查,包括维生素D和欧米茄-3试验 (VITAL).
主要成果:
- 观察数据表明,维生素D缺乏与SAMS风险增加之间存在联系.
- 最近的大型临床试验,如VITAL,发现维生素D补充剂在预防SAMS方面没有显著的益处.
- 在最近的试验中,维生素D补充剂没有降低他类药物停用率.
结论:
- 关于维生素D在SAMS管理中的作用,存在相互矛盾的证据.
- 目前的临床试验数据不支持常规使用维生素D补充剂来预防或治疗SAMS.
- 需要进一步研究替代策略,以改善他类药物的耐受性和坚持性.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
584
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
584
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
660
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
660
Skeletal Muscle Relaxants: Adverse Effects
346
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
346
Disorders of the Skeletal Muscle
903
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
903
Myasthenia Gravis: Diagnostic Tests
695
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
695
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K


